期刊文献+

西安市1995-2008年检出脊髓灰质炎疫苗病毒的急性弛缓性麻痹病例流行病学分析 被引量:6

Epidemiologic analysis on acute flaccid paralysis cases with isolation of poliovirus strains in Xi'an in 1995-2008
暂未订购
导出
摘要 分析脊髓灰质炎(脊灰)病毒(PV)的急性弛缓性麻痹(AFP)病例流行病学特征,提高对疫苗衍生脊灰病毒(VDPVs)和循环的疫苗衍生脊灰病毒(cVDPVs)的认识,增加AFP病例监测系统敏感性。对西安市1995-2008年检出的PV阳性AFP病例进行流行病学分析。对疫苗变异PV采用VP1基因核苷酸序列测定方法进行分子生物性状分析。西安市1995-2008年共检出PV13株,检出率4.29%。分离到的PV以II、III型为主,AFP病例散在发生,无聚集性。未全程免疫儿童(全程免疫儿童,年龄以≤1岁儿童为主(84.62%)。麻痹残留率高达84.62%。脊灰相关病例(VAPP)的发生危险性为0.24/100万。型内特征鉴定有1株为疫苗变异PV,经VP1基因核苷酸序列测定未达到VDPV的分类标准。维持无脊灰阶段,存在着VDPV和发生cVDPVs的可能,在保持高水平脊髓灰质炎疫苗(OPV)免疫覆盖率的同时,高质量的AFP病例流行病学监测和病毒学监测工作,具有重要的现实意义。 The epidemiological characters of AFP cases with poliovirus was analyzed in order to acquire more knowledge of vaccine-derived poliovirus(VDPVs) and circulating vaccine-derived poliovirus(cVDPVs)and increase the sensitivity of AFP surveillance system.XI'an AFP cases with poliovirus in 1995-2008 were analyzed.The molecular characters of vaccine-derived poliovirus were analyzed by VP1 genomic sequencing technique.13 poliovirus strains were isolated from AFP cases from 1995 to 2008.The isolated rate is 4.29%.Most of them are type Ⅱ and type Ⅲ strains and AFP cases are sporadic.Number of children with full immunization is more than children with no full immunization.Most of them are under 1 year old(84.62%) and the rate of paralysis residue is 84.62%.The incidence risk rate of vaccine-associated paralytic poliomyelitis(VAPP) is 0.24/1000000.One strain has been identified as vaccine-variant poliovirus which variant rate of VP1 sequence did not reach the classified standard of VDPV.VDPV emergence and cVDPVs circulation still possibly occur in course of polio-free.It is important realistic meaning to keep high-level OPV immunization rate,high quality AFP case epidemiologic investingation and virus surveillance.
出处 《微生物学免疫学进展》 2010年第3期32-35,共4页 Progress In Microbiology and Immunology
关键词 急性弛缓性麻痹 疫苗衍生脊灰病毒 Acute flaccid paralysis(AFP) Vaccine-derived Poliovirus(VDPVs)
  • 相关文献

参考文献8

二级参考文献46

共引文献129

同被引文献35

  • 1莫想换,毛东波.2000~2004年东莞市疫苗相关麻痹型脊髓灰质炎病例流行病学分析[J].华南预防医学,2006,32(3):33-34. 被引量:3
  • 2黄利明,许二萍,杨洛贤,刘艳,张小平,朱冰.杭州市急性弛缓性麻痹病例检出疫苗相关株病毒的调查分析[J].中国预防医学杂志,2007,8(1):5-7. 被引量:3
  • 3卫生部办公厅.《疫苗相关麻痹型脊髓灰质炎病例诊断依据及治疗参考意见》[EB/OL].(2008-02-04)[2013-11-06].http://www.nhfpc.gov.cn/yzygj/s3585u/200804/82b7753e51d84b0f93b4089420tb3b53.shtml.
  • 4Kew OM, Sutter RW, de Gourville EM, et al. Vaccine-derived polioviruses and the endgame strategy for global polio eradication [J].AnnuRevMicrobiol, 2005, 59: 587-635.
  • 5卫生部办公厅.关于印发《疫苗相关麻痹型脊髓灰质炎病例诊断依据及治疗参考意见》的通知[S].2008:1-4.
  • 6中华人民共和国卫生部.WS294-2008脊髓灰质炎诊断标准[S].北京:人民卫生出版社,2009.
  • 7中华人民共和国卫生部.疫苗相关麻痹型脊髓灰质炎病例诊断依据及治疗参考意见[EB/OL].(2008-02-04)[2016-07-03].http://www.rrch.gov.en/mohbgt/pwl0804/200805/35149.shtml.
  • 8World Health Organization. Update on vaccine - derived poliovirus- es detected worldwide, April 2011-June 2012[J]. Weekly epidemi- ological record, 2012, 87(38): 358 - 368.
  • 9世界卫生组织.全球消灭脊髓灰质炎前的脊髓灰质炎疫苗及其免疫接种:WHO立场文件[EB/OL].[2016-07-04].http://www.who.int/immunization/documents/PP_Polio_CH.pdf7.ua=1.
  • 10黄铭华,李放军,李俊华,方明礼,谢超,张淑君.运用Topsis法综合评价湖南省AFP病例监测质量[J].中国预防医学杂志,2008,9(3):172-175. 被引量:7

引证文献6

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部